has been cited by the following article(s):
|
[1]
|
BRIDGE-DS study: evaluating the effectiveness and safety of dapagliflozin/sitagliptin combination in type 2 diabetes mellitus patients with heart failure
Cardiovascular Endocrinology & Metabolism,
2025
DOI:10.1097/XCE.0000000000000334
|
|
|
|